Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Guillem Pascual-Pasto, Miriam Bazan-Peregrino, Nagore G. Olaciregui, Camilo A. Restrepo-Perdomo, Ana Mato-Berciano, Daniela Ottaviani, Klaus Weber, Genoveva Correa, Sonia Paco, Monica Vila-Ubach, Maria Cuadrado-Vilanova, Helena Castillo-Ecija, Gaia Botteri, Laura Garcia-Gerique, Helena Moreno-Gilabert, Marta Gimenez-Alejandre, Patricia Alonso-Lopez, Marti Farrera-Sal, Silvia Torres-Manjon, Dolores Ramos-Lozano, Rafael Moreno, Isabelle Aerts, François Doz, Nathalie Cassoux, Elodie Chapeaublanc, Montserrat Torrebadell, Monica Roldan, Andrés König, Mariona Suñol, Joana Claverol, Cinzia Lavarino, Torres Carmen de, Ligia Fu, François Radvanyi, Francis L. Munier, Jaume Catalá-Mora, Jaume Mora, Ramón Alemany, Manel Cascalló, Guillermo L. Chantada, Angel M. Carcaboso

Open source

DOI: 10.1126/scitranslmed.aat9321
Published: 2019-01-23
Container: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.aat9321,
  title = {Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01},
  author = {Guillem Pascual-Pasto and Miriam Bazan-Peregrino and Nagore G. Olaciregui and Camilo A. Restrepo-Perdomo and Ana Mato-Berciano and Daniela Ottaviani and Klaus Weber and Genoveva Correa and Sonia Paco and Monica Vila-Ubach and Maria Cuadrado-Vilanova and Helena Castillo-Ecija and Gaia Botteri and Laura Garcia-Gerique and Helena Moreno-Gilabert and Marta Gimenez-Alejandre and Patricia Alonso-Lopez and Marti Farrera-Sal and Silvia Torres-Manjon and Dolores Ramos-Lozano and Rafael Moreno and Isabelle Aerts and François Doz and Nathalie Cassoux and Elodie Chapeaublanc and Montserrat Torrebadell and Monica Roldan and Andrés König and Mariona Suñol and Joana Claverol and Cinzia Lavarino and Torres Carmen de and Ligia Fu and François Radvanyi and Francis L. Munier and Jaume Catalá-Mora and Jaume Mora and Ramón Alemany and Manel Cascalló and Guillermo L. Chantada and Angel M. Carcaboso},
  year = {2019},
  journal = {Science Translational Medicine},
  doi = {10.1126/scitranslmed.aat9321},
  url = {https://doi.org/10.1126/scitranslmed.aat9321}
}

RIS

TY  - JOUR
TI  - Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
AU  - Guillem Pascual-Pasto
AU  - Miriam Bazan-Peregrino
AU  - Nagore G. Olaciregui
AU  - Camilo A. Restrepo-Perdomo
AU  - Ana Mato-Berciano
AU  - Daniela Ottaviani
AU  - Klaus Weber
AU  - Genoveva Correa
AU  - Sonia Paco
AU  - Monica Vila-Ubach
AU  - Maria Cuadrado-Vilanova
AU  - Helena Castillo-Ecija
AU  - Gaia Botteri
AU  - Laura Garcia-Gerique
AU  - Helena Moreno-Gilabert
AU  - Marta Gimenez-Alejandre
AU  - Patricia Alonso-Lopez
AU  - Marti Farrera-Sal
AU  - Silvia Torres-Manjon
AU  - Dolores Ramos-Lozano
AU  - Rafael Moreno
AU  - Isabelle Aerts
AU  - François Doz
AU  - Nathalie Cassoux
AU  - Elodie Chapeaublanc
AU  - Montserrat Torrebadell
AU  - Monica Roldan
AU  - Andrés König
AU  - Mariona Suñol
AU  - Joana Claverol
AU  - Cinzia Lavarino
AU  - Torres Carmen de
AU  - Ligia Fu
AU  - François Radvanyi
AU  - Francis L. Munier
AU  - Jaume Catalá-Mora
AU  - Jaume Mora
AU  - Ramón Alemany
AU  - Manel Cascalló
AU  - Guillermo L. Chantada
AU  - Angel M. Carcaboso
PY  - 2019
JO  - Science Translational Medicine
DO  - 10.1126/scitranslmed.aat9321
UR  - https://doi.org/10.1126/scitranslmed.aat9321
ER  -

APA

Pascual-Pasto, G., Bazan-Peregrino, M., Olaciregui, N. G., Restrepo-Perdomo, C. A., Mato-Berciano, A., Ottaviani, D., Weber, K., Correa, G., Paco, S., Vila-Ubach, M., Cuadrado-Vilanova, M., Castillo-Ecija, H., Botteri, G., Garcia-Gerique, L., Moreno-Gilabert, H., Gimenez-Alejandre, M., Alonso-Lopez, P., Farrera-Sal, M., Torres-Manjon, S., Ramos-Lozano, D., Moreno, R., Aerts, I., Doz, F., Cassoux, N., Chapeaublanc, E., Torrebadell, M., Roldan, M., König, A., Suñol, M., Claverol, J., Lavarino, C., de, T. C., Fu, L., Radvanyi, F., Munier, F. L., Catalá-Mora, J., Mora, J., Alemany, R., Cascalló, M., Chantada, G. L., & Carcaboso, A. M. (2019). Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aat9321

Source records

crossref · retrieved 2026-09-27T12:47:33.738Z